Hereditary hemochromatosis: data from a single center Copenhagen cohort

References

• Milman N, Pedersen P. Evidence that the Cys282Tyr mutation of the HFE gene originated from a population in Southern Scandinavia and spread with the Vikings. Clin Genet. 2003;64(1):36–47.
   PubMed Web of Science ®Google Scholar
• Powell LW, Seckington RC, Deugnier Y. Haemochromatosis. Lancet. 2016;388(10045):706–716.
   PubMed Web of Science ®Google Scholar
• Feder JN, Gnirke A, Thomas W, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet. 1996;13(4):399–408.
   PubMed Web of Science ®Google Scholar
• Allen KJ, Gurrin LC, Constantine CC, Osborne NJ, et al. Iron-overload-related disease in HFE hereditary hemochromatosis. N Engl J Med. 2008;358(3):221–230.
   PubMed Web of Science ®Google Scholar
• Lim DR, Vidyasankar G, Phua C, et al. Clinical penetrance of hereditary hemochromatosis-related end-organ damage of C282Y homozygosity, a newfoundland experience. Clin Transl Gastroenterol. 2020;11(11):e00258.
   PubMedGoogle Scholar
• Aguilar-Martinez P, Bismuth M, Blanc F, et al. The Southern French registry of genetic hemochromatosis: a tool for determining clinical prevalence of the disorder and genotype penetrance. Haematologica. 2010;95(4):551–556.
   PubMed Web of Science ®Google Scholar
• Pedersen P, Melsen GV, Milman N. Frequencies of the haemochromatosis gene (HFE) variants C282Y, H63D and S65C in 6,020 ethnic Danish men. Ann Hematol. 2008;87(9):735–740.
   PubMed Web of Science ®Google Scholar
• Bassett ML, Halliday JW, Ferris RA, et al. Diagnosis of hemochromatosis in young subjects: predictive accuracy of biochemical screening tests. Gastroenterology. 1984;87(3):628–633.
   PubMed Web of Science ®Google Scholar
• Brissot P, De BF. Current approaches to the management of hemochromatosis. Hematology Am Soc Hematol Educ Program. 2006;2006(1):36–41.
   Google Scholar
• Beutler E, Felitti VJ, Koziol JA, et al. Penetrance of 845G–> A (C282Y) HFE hereditary haemochromatosis mutation in the USA. Lancet. 2002;359(9302):211–218.
   PubMed Web of Science ®Google Scholar
• Milman NT, Schioedt FV, Junker AE, et al. Diagnosis and treatment of genetic HFE-hemochromatosis: the Danish aspect. Gastroenterology Res. 2019;12(5):221–232.
   PubMed Web of Science ®Google Scholar
• Valenti L, Fracanzani AL, Rossi V, et al. The hand arthropathy of hereditary hemochromatosis is strongly associated with iron overload. J Rheumatol. 2008;35(1):153–158.
   PubMed Web of Science ®Google Scholar
• Elmberg M, Hultcrantz R, Simard JF, et al. Risk of ischaemic heart disease and cardiomyopathy in patients with haemochromatosis and in their first-degree relatives: a nationwide, population-based study. J Intern Med. 2012;272(1):45–54.
   PubMed Web of Science ®Google Scholar
• Skinner C, Kenmure AC. Haemochromatosis presenting as congestive cardiomyopathy and responding to venesection. Br Heart J. 1973;35(4):466–468.
   PubMedGoogle Scholar
• Wood MJ, Powell LW, Dixon JL, et al. Clinical cofactors and hepatic fibrosis in hereditary hemochromatosis: the role of diabetes mellitus. Hepatology. 2012;56(3):904–911.
   PubMed Web of Science ®Google Scholar
• Ellervik C, Mandrup-Poulsen T, Nordestgaard BG, et al. Prevalence of hereditary haemochromatosis in late-onset type 1 diabetes mellitus: a retrospective study. Lancet. 2001;358(9291):1405–1409.
   PubMed Web of Science ®Google Scholar
• Milman NT, Schiodt FV, Junker AE, et al. Genetic HFE-haemochromatosis. Ugeskr Laeger. 2018;180(51):V09180619.
   PubMedGoogle Scholar
• Adhoute X, Foucher J, Laharie D, et al. Diagnosis of liver fibrosis using FibroScan and other noninvasive methods in patients with hemochromatosis: a prospective study. Gastroenterol Clin Biol. 2008;32(2):180–187.
   PubMedGoogle Scholar
• Friedrich-Rust M, Ong MF, Martens S, et al. Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology. 2008;134(4):960–974.
   PubMed Web of Science ®Google Scholar
• Lurie Y, Webb M, Cytter-Kuint R, et al. Non-invasive diagnosis of liver fibrosis and cirrhosis. World J Gastroenterol. 2015;21(41):11567–11583.
   PubMed Web of Science ®Google Scholar
• Ommen SR, Mital S, Burke MA, et al. AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: a report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice guidelines. J Thorac Cardiovasc Surg. 2021;162(1):e23–e106.
   PubMed Web of Science ®Google Scholar
• Saberzadeh-Ardestani B, Karamzadeh R, Basiri M, et al. Type 1 diabetes mellitus: cellular and molecular pathophysiology at a glance. Cell J. 2018;20(3):294–301.
   PubMed Web of Science ®Google Scholar
• Koefoed P, Dalhoff K, Dissing J, et al. HFE mutations and hemochromatosis in Danish patients admitted for HFE genotyping. Scand J Clin Lab Invest. 2002;62(7):527–535.
   PubMed Web of Science ®Google Scholar
• Pietrangelo A. Hereditary hemochromatosis: pathogenesis, diagnosis, and treatment. Gastroenterology. 2010;139(2):393–408.
   PubMed Web of Science ®Google Scholar
• Elmberg M, Hultcrantz R, Simard JF, et al. Increased risk of arthropathies and joint replacement surgery in patients with genetic hemochromatosis: a study of 3,531 patients and their 11,794 first-degree relatives. Arthritis Care Res. 2013;65(5):678–685.
   Web of Science ®Google Scholar
• Bell H, Berg JP, Undlien DE, et al. The clinical expression of hemochromatosis in Oslo, Norway. Excessive oral iron intake may lead to secondary hemochromatosis even in HFE C282Y mutation negative subjects. Scand J Gastroenterol. 2000;35(12):1301–1307.
   PubMed Web of Science ®Google Scholar
• Adams PC, Deugnier Y, Moirand R, et al. The relationship between iron overload, clinical symptoms, and age in 410 patients with genetic hemochromatosis. Hepatology. 1997;25(1):162–166.
   PubMed Web of Science ®Google Scholar
• Gallego CJ, Burt A, Sundaresan AS, Ye Z, et al. Penetrance of hemochromatosis in HFE genotypes resulting in p.Cys282Tyr and p.[Cys282Tyr];[His63Asp] in the eMERGE network. Am J Hum Genet. 2015;97(4):512–520.
   PubMed Web of Science ®Google Scholar
• Milman N. Hereditary haemochromatosis in Denmark 1950-1985. Clinical, biochemical and histological features in 179 patients and 13 preclinical cases. Dan Med Bull. 1991;38(4):385–393.
   PubMedGoogle Scholar
• Milman N, Pedersen P, Steig T, et al. Clinically overt hereditary hemochromatosis in Denmark 1948-1985: epidemiology, factors of significance for long-term survival, and causes of death in 179 patients. Ann Hematol. 2001;80(12):737–744.
   PubMed Web of Science ®Google Scholar
• Niederau C, Fischer R, Sonnenberg A, et al. Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis. N Engl J Med. 1985;313(20):1256–1262.
   PubMed Web of Science ®Google Scholar